How a new tablet interacts with other drugs in healthy adults
This study tests how a new tablet (called VC005) interacts with other drugs in healthy adults. It helps researchers understand how the drug is processed by the body, which is important for future dosing in patients.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You need to weigh at least 50 kg (110 lbs) if you are male, or 45 kg (99 lbs) if you are female, with a BMI between 19 and 26.
- You must be willing to use effective birth control during the study and for 3 months after.
- You cannot have a history of drug or alcohol abuse, or have donated more than 400 mL of blood in the last 3 months.
- You must not have taken any prescription or over-the-counter drugs, vitamins, or herbal medicines within 14 days before the study starts.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new tablet called VV261 in healthy volunteers to see how safe it is and how the body processes it. It is an early study to gather important information before larger trials.
This study tests a new medicine called VV261 in healthy volunteers. It looks at whether the medicine is safe and how the body handles it. You may be able to join if you are a healthy adult aged 18-45 and meet certain health requirements.
This early-stage study tests how a new experimental medication (HSK55879) is tolerated and processed by the body in healthy volunteers. Researchers will also check how food affects the drug's absorption to help determine safe dosing for future patient studies.
This trial tests a new drug (VB19055) in healthy volunteers to see how safe it is and how the body processes it. Participants will be watched closely and may help find the right dose for future studies.
This trial studies how food changes the way your body processes a new medicine called VV119. It helps make sure the drug works safely and effectively. Healthy adults are needed to participate.
This early-phase trial tests the safety of KMY tablets in healthy adults. It helps determine how well the drug is tolerated and how it moves through the body.
Hear when a new Healthy Adult Participants trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.